Atlas Trials

An Expanded Access Treatment Protocol of Zanidatamab (ZW25) in Patients With HER2-Positive Advanced Biliary Tract Cancer

Clinical trial NCT04578444 · NO_LONGER_AVAILABLE

Trial details

NCT number
NCT04578444
Sponsor
Jazz Pharmaceuticals
Status
NO_LONGER_AVAILABLE
Study type
EXPANDED_ACCESS
HER2-Positive Advanced Biliary Tract Cancer

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.